0001123292-15-001273.txt : 20151030 0001123292-15-001273.hdr.sgml : 20151030 20151030180954 ACCESSION NUMBER: 0001123292-15-001273 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130918 FILED AS OF DATE: 20151030 DATE AS OF CHANGE: 20151030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hambleton Julie CENTRAL INDEX KEY: 0001578771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 151188802 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-09-18 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001578771 Hambleton Julie C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP & Chief Medical Officer Common Stock 2013-09-18 4 P 0 800 14.75 A 800 I By husband's IRA Common Stock 2013-11-06 4 P 0 500 10.10 A 1300 I By husband's IRA Common Stock 2014-08-22 4 P 0 400 10.75 A 1700 I By husband's IRA Common Stock 2013-09-30 4 P 0 64 13.70 A 64 I By son's custodial account Common Stock 85919 D Includes 179 shares granted to the reporting person by the Issuer pursuant to a company match under the Issuer's 401(k) plan. /s/ Francis Sarena, Attorney-in-Fact 2015-10-30